Perkins Caufield & Byers Xi… Net Worth
What’s Perkins Xi’s mailing address?
Perkins’s mailing address filed with the SEC is 2750 SAND HILL ROAD2750 SAND HILL ROAD, , MENLO PARKMENLO PARK, CACA, 9402594025.
Insider trading at Progyny
Over the last few years, insiders at Progyny have traded over $35,557,414 worth of Progyny stock and bought 76,923 units worth $999,999 . The most active insider traders include Plc Glaxosmithkline, David J Schlanger, and Peter Anevski. On average, Progyny executives and independent directors trade stock every 1 days with the average trade being worth of $8,293,265. The most recent stock trade was executed by Beth C Seidenberg on 29 October 2019, trading 76,923 units of PGNY stock currently worth $999,999.
What does Progyny do?
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
Progyny executives and stock owners
Progyny executives and other stock owners filed with the SEC include:
- Karin Ajmani, President – Healthcare Services
- Gary Harton, Senior Vice President – Clinical Affairs
- George Nassef, Executive Vice President – Operations & Legal, Chief Technology Officer
- Edwin Neumann, Chief Financial Officer
- Gina Bartasi, Chief Executive Officer, Director
- Plc Glaxosmithkline, 10% owner
- Beth C Seidenberg, Director
- Perkins Caufield & Byers Xi…,
- Norman Payson, Director
- David J Schlanger, Chief Executive Officer
- Peter Anevski, Pres., Chief Fin & Op. Officer
- Kevin K Gordon, Director
- Jennifer Bealer, EVP, General Counsel
- Jeffrey G Park, Director
- Cheryl Scott, Director